 Bevacizumab is an anti-VEGF agent used in approved for use in metastatic colorectal carcinoma FDA Approved. This study analyzes the safety and efficacy of off-label Intravitreal Injection of bevacizumab Avastin for CNVM, Macular oedema due to diabetic retinopathy, vascular occlusion and other retinal disorders. 